VeriMomsh-oligopeptide-2 hamilelikte güvenli mi?
No harmonised CLP reproductive classification (ECHA Annex VI), no SCCS/CIR safety assessment indicating reproductive risk, and no peer‑reviewed reproductive/toxicology studies identified for SH‑Oligopeptide‑2. As a short synthetic peptide (large, hydrophilic molecule) systemic absorption from usual topical cosmetic use is expected to be negligible, so no pregnancy hazard is indicated (sources: ECHA Annex VI no listing; CosIng/PubChem entries; absence of literature on PubMed).
Pregnancy-safe products containing sh-oligopeptide-2
Related ingredients
Frequently asked questions
- sh-oligopeptide-2 hamilelikte güvenli mi?
- No harmonised CLP reproductive classification (ECHA Annex VI), no SCCS/CIR safety assessment indicating reproductive risk, and no peer‑reviewed reproductive/toxicology studies identified for SH‑Oligopeptide‑2. As a short synthetic peptide (large, hydrophilic molecule) systemic absorption from usual topical cosmetic use is expected to be negligible, so no pregnancy hazard is indicated (sources: ECHA Annex VI no listing; CosIng/PubChem entries; absence of literature on PubMed).
- sh-oligopeptide-2 emzirirken güvenli mi?
- Same rationale as pregnancy: no regulatory reproductive flags or published evidence of reproductive or lactation effects for SH‑Oligopeptide‑2. Large hydrophilic peptides used topically generally show negligible dermal absorption and are not reported to transfer into breastmilk in the literature searched (sources: CosIng, PubChem, PubMed search negative).
- sh-oligopeptide-2 bebek cildi için güvenli mi?
- No evidence of reproductive or developmental toxicity specific to infants. Mechanistic concerns are not identified. Dermal exposure for infants is higher relative to bodyweight and barrier immaturity can increase percutaneous uptake; whereas adult topical absorption is expected negligible, infant exposure is conservatively scored higher (exposure +1) in absence of infant‑specific ADME data (sources: CosIng/PubChem for identity; absence of adverse reports in PubMed/ECHA).
- VeriMom sh-oligopeptide-2 nasıl puanlıyor?
- VeriMom sh-oligopeptide-2'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte sh-oligopeptide-2 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.